Clinical trial
Efficacy and Safety of Chromium as a Therapeutic Intervention for Insulin Resistance Associated With Obesity
NCT00997659 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Chromium as a Therapeutic Intervention for Insulin Resistance Associated With Obesity
- Lead sponsor
- Stony Brook University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- May 31, 2010
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.